Your institution may have access to this item. Find your institution then sign in to continue.
Title
Aliskiren/valsartan: withdrawal of marketing authorization application.
Abstract
The article reports on a 2010 decision which the manufacturer of the combination drug aliskiren/valsartan made to notify the European Medicines Agency about its decision to withdraw the application for a centralized marketing authorization for the drug.